(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
Degenerative Neurological and Neuromuscular Disease · 2026-05 · Volume 16 · 1-16
DOI: 10.2147/dnnd.s574524 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2026-05. Verfasst von H Lawrence Remmel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Atossa Therapeutics Inc., Seattle, WA, USA. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atossa Therapeutics Inc., Seattle, WA, USA.
- Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
ORCID-Profile: H Lawrence Remmel, Sandra S Hammer, Scott M Blackburn, Steven C Quay
Zitieren
APA
Remmel, H. L., Hammer, S. S., Blackburn, S. M., & Quay, S. C. (2026). (Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective. Degenerative Neurological and Neuromuscular Disease, Volume 16, 1-16. https://doi.org/10.2147/dnnd.s574524
Vancouver
Remmel HL, Hammer SS, Blackburn SM, Quay SC. (Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective. Degenerative Neurological and Neuromuscular Disease. 2026;Volume 16:1-16. doi:10.2147/dnnd.s574524
BibTeX
@article{Remmel2026,
author = {Remmel, H Lawrence and Hammer, Sandra S and Blackburn, Scott M and Quay, Steven C},
title = {(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective},
journal = {Degenerative Neurological and Neuromuscular Disease},
year = {2026},
volume = {Volume 16},
pages = {1--16},
doi = {10.2147/dnnd.s574524}
}
EUVIMED